Pulmonary Hypertension Impact Factor
Pulmonary arterial
hypertension (PAH) is a social movement disease affecting the arteries of the lungs. The pulmonary arteries carry blood from the right side of the heart via the lungs. The definition requires specific hemodynamic parameters (body measure the measurements of the forces involved in the circulation of blood) be measured and met. Normally
hypertension otherwise known as high blood pressure, pulmonary arterial
hypertension (PAH) cannot be easily measured with a blood pressure cuff. There are different tests such as echocardiograms that may point towards a diagnosis of pulmonary arterial
hypertension (PAH) but right heart catheterization is the only way to definitively measure the required hemodynamics necessary to make the diagnosis. A normal pulmonary artery pressure for a healthy patient is 12-16 mmHg and a normal wedge pressure is 6-12 mmHg. Normally, the pressures in the right side of the heart and the pulmonary arteries are elevated while the pressures in the left side of the heart are normal. These specific pressures can only be measured accurately through right heart catheterization. Pulmonary
hypertension varies from person to person, so your treatment plan are going to be specific to your needs. First, your doctor will treat the explanation for your condition. For example, if emphysema is causing the matter , you will need to treat that to enhance your pulmonary hypertension.Most people also get treatment to enhance their breathing, which makes it easier to be active and do daily tasks.
High Impact List of Articles
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Assessing nocturia in clinical trials
Svetlana Avulova , Jeffrey P Weiss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Assessing nocturia in clinical trials
Svetlana Avulova , Jeffrey P Weiss
Review: Clinical Trail Outcomes: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
Relevant Topics in Clinical